-Bloomberg
Legend Biotech Reports Extension Of PDUFA Date For Cilta-Cell To Feb. 28, 2022
Legend Biotech Corporation (NASDAQ:LEGN) (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, today announced that the U.S. Food and Drug Administration has